OrthoPediatrics Corp. (KIDS)
Company Description
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally.
The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system.
The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.
OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
| Country | United States |
| IPO Date | Oct 13, 2017 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 562 |
| CEO | David R. Bailey |
Contact Details
Address: 2850 Frontier Drive Warsaw, Indiana United States | |
| Website | https://www.orthopediatrics.com |
Stock Details
| Ticker Symbol | KIDS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001425450 |
| CUSIP Number | 68752L100 |
| ISIN Number | US68752L1008 |
| Employer ID | 26-1761833 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David R. Bailey | President, Chief Executive Officer & Director |
| Fred L. Hite | Chief Financial Officer, Principal Financial & Accounting Officer, Chief Operating Officer and Director |
| Daniel J. Gerritzen J.D. | Executive Vice President of Legal, General Counsel & Secretary |
| Gregory A. Odle | President of Scoliosis |
| Joseph W. Hauser | President of Trauma, Deformity Correction & OPSB |
| Kevin L. Unger CHE, MBA/MSHA | President of Enabling Technologies |
| Mark Karshner | Senior Vice President of International Sales |
| Mark C. Throdahl | Executive Chairman |
| Ray Garrison | Senior Vice President of Quality & Regulatory and Clinical |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | DEFR14A | Filing |
| Apr 02, 2025 | ARS | Filing |
| Apr 02, 2025 | DEFA14A | Filing |
| Apr 02, 2025 | DEF 14A | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 18, 2025 | 4 | Filing |
| Mar 06, 2025 | 8-K | Current Report |